SB INVESTMENT ADVISERS (UK) LTD - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
SB INVESTMENT ADVISERS (UK) LTD ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$156,329,464
-61.8%
16,684,0410.0%1.29%
-58.7%
Q2 2023$409,259,526
-4.0%
16,684,041
-8.9%
3.12%
-11.0%
Q1 2023$426,304,957
-16.9%
18,319,938
-9.6%
3.50%
-18.1%
Q4 2022$512,768,831
+20.4%
20,259,535
-8.3%
4.28%
+31.3%
Q3 2022$425,823,000
-24.7%
22,086,280
-0.6%
3.26%
-27.5%
Q2 2022$565,858,000
-1.0%
22,216,6440.0%4.50%
+65.9%
Q1 2022$571,412,000
-38.6%
22,216,6440.0%2.71%
-0.0%
Q4 2021$930,211,000
-5.5%
22,216,644
-1.8%
2.71%
-11.2%
Q3 2021$984,277,000
-8.0%
22,616,6660.0%3.05%
+45.7%
Q2 2021$1,069,315,000
-7.8%
22,616,6660.0%2.10%
+4.3%
Q1 2021$1,159,556,000
+91.4%
22,616,6660.0%2.01%
-17.7%
Q4 2020$605,674,000
-22.0%
22,616,6660.0%2.44%
-63.4%
Q3 2020$776,430,000
-16.2%
22,616,6660.0%6.67%
-33.9%
Q2 2020$926,605,000
+19.6%
22,616,6660.0%10.10%
+20.9%
Q1 2020$775,073,000
+172.5%
22,616,6660.0%8.35%
+167.9%
Q4 2019$284,405,00022,616,6663.12%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders